key: cord-0806399-g1c7mv0j authors: Schoen, Corina N.; Morgan, Elizabeth; Leftwich, Heidi K.; Rogers, Christine; Soorneedi, Anand; Suther, Cassandra; Moore, Matthew D. title: Failure to Detect SARS-CoV-2 RNA in the Air During Active Labor in Mothers Who Recently Tested Positive date: 2022-04-27 journal: Front Public Health DOI: 10.3389/fpubh.2022.881613 sha: 1b6fa149201baa1804f30ffa2a86b8bdf52e1953 doc_id: 806399 cord_uid: g1c7mv0j The risk of potential SARS-CoV-2 transmission by infected mothers during labor and delivery has not been investigated in-depth. This work collected air samples close to (respiratory droplets) and more distant from (aerosol generation) unvaccinated patients who had previously tested positive for SARS-CoV-2 during labor within 5 days of a positive test. All but one of the patients wore masks during the delivery, and delivery was carried out in either birthing or negative pressure isolation rooms. Our work failed to detect SARS-CoV-2 RNA in any air samples for all of the six patients who gave birth vaginally, despite validation of the limit of detection of the samplers. In sum, this brief report provides initial evidence that the risk of airborne transmission of SARS-CoV-2 during labor may be mitigated by the use of masks and high ventilation rates common in many modern U.S. medical facilities; however more work is needed to fully evaluate the risk of SARS-CoV-2 transmission during labor and maternal pushing. About 2 years since the beginning of the SARS-CoV-2 pandemic, questions remain regarding transmission of this rapidly spreading viral infection. Implementing appropriate infection control measures is crucial to protecting health care workers and to limit nosocomial and community spread (1) . SARS-CoV-2 is primarily thought to be transmitted via the airborne route, but the proportion of larger respiratory droplets vs. aerosols and the distance over which transmission can occur is hotly debated (2, 3) . During the first stage of labor, the cervix dilates from 0 to 10 cm. There is no active pushing during that time period. Specifically, active labor is the time from 6 cm through 10 cm cervical dilation. The second stage of labor occurs from 10 cm dilation through delivery of the neonate. At this point there is active maternal pushing and expulsive efforts, including increased respiratory efforts and occasional increased vocalizations as well. Transmission through respiratory droplets and aerosols during parturition is increasingly plausible, given the increased respiratory effort required during the 2nd stage of labor. Other actions such as coughing, sneezing, and volume of vocalization can also produce infectious aerosols of SARS-CoV-2, each which can occur during the 2nd stage of labor (4) (5) (6) . We aimed to determine if SARS-CoV-2 would be present in the air during active labor and the 2nd stage of labor in participants diagnosed with COVID-19. This study was performed at Baystate Medical Center, Springfield, MA and UMass Memorial Hospital, Worcester, MA from May 2020 through January 2021. Pregnant patients who tested positive for SARS-CoV-2 between 0 and 7 days prior to anticipated vaginal delivery were included in the study. Patients were encouraged to wear a mask throughout labor and delivery as tolerated, though they could remove the mask if they could not adequately push during delivery with it in place. This occurred for one subject, who needed to remove their mask, while the other five subjects were able to wear masks. Patients were preferentially placed in a negative pressure room when available (a room maintained with a higher rate of exhaust than air supply such that there is a continuous inward flow of air) with a high internal ventilation rate of about 15 air changes per hour. When negative pressure room was not available, a standard labor and delivery room with the same amount of air changes utilized. Two of the six patients were able to be placed in negative pressure rooms, while the other four were in standard labor and delivery rooms. Active air sampling was performed in two locations. Sampler 1 was at bedside, positioned midway between the subject's head and hips at about 4 feet high. Sampler 2 was located 6-10 feet from the subject's head, ∼5 feet high. Air was sampled with an E-MaxX IAQ air sampling pump drawing 20 L/min continuously through a polycarbonate cassette holding a PFTE filter (SKC, Inc). Samplers were run for at least 30 min with a total air volume of at least 600 L. Buccal and perianal swabs were obtained at time of delivery. Samples were stored at 4 • C until elution and extraction. Elution was carried out by transferring the PFTE membrane to a tube containing 1.5 mL of sterile PBS (pH 7.2) and vortexing rigorously for 15 s. Extraction was performed with Trizol reagent and ethanol precipitation. RNA pellets were resuspended in buffer containing 4 U/µl Rnase inhibitor and stored immediately at −80 • C until use. Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) was performed targeting the RNA-dependent reverse transcriptase (RdRp) and envelope protein (E) regions of the viral genome (7) . Plasmids containing target RdRp and E sequences were used as positive controls (IDT Technologies). Initial optimization of elution efficiency and detection of virus captured on the sampler matrix was performed with a SARS-CoV-2 coronavirus surrogate (human coronavirus 229E) to ensure proper elution and detection and calculate the estimated limit of detection of the assay. For this assay, 100 µl of human coronavirus 229E was spotted onto the PFTE membrane, dried in a biosafety cabinet (∼1 h), and subjected to the elution and extraction protocol as described above. Virus stocks were relatively quantified by serial elution of extract with standard curve to estimate of RT-qPCR Units of virus. Recovery efficiency was calculated by the percentage of recovered viral RT-qPCR Units out of input (spotted) viral RT-qPCR Units. Limit of detection was calculated as the lowest level of input virus that was able to yield a reliably positive signal for replicates. Ct values above 40 were considered inconclusive. All control experiments were run in triplicate, and each RT-qPCR reaction run in duplicate wells. Six symptomatic patients with SARS-CoV-2 had air samples processed (two filters per patient representing the two samplers above, 12 total); all were PCR positive via nasopharyngeal swab between 0 and 5 days of admission. No patients were positive 6 or 7 days before labor. Subject 2-01 was not able to tolerate wearing a mask through the entire labor and delivery process. All of the other subjects were able to wear their masks for the entire period (active labor through delivery of the neonate). Subject 5 was positive on day of admission via nasopharyngeal swab (consent not given for other swabs). Of the 6 patient paired air samples processed, no samples registered as positive (Table 1) , however all positive external RT-qPCR reaction controls containing purified plasmid provided consistent positive signal. The recovery efficiency of captured surrogate virus from the membrane was 12.4%, and the limit of detection of this was 14.4 RT-qPCR Units/mL. It should be noted that RNA was tested, and the current sampling configuration and parameters would be expected to yield positive results given previous reports with RT-qPCR (8-10). PCR testing was negative for the 6 patient buccal and perianal swabs. Information about the Ct values of the patients' positive tests from centralized testing laboratories was not available as patient identifiers with the testing were not made available to the authors. This study investigated the potential for aerosolization of SARS-CoV-2 in positive mothers during the second stage of vaginal delivery. Air sampling both beside the patient and 6-10 feet away failed to detect SARS-CoV-2 RNA in all samples tested, suggesting that either generation of SARS-CoV-2 aerosols is not very common during vaginal delivery in settings with consistent mask use by laboring patients or aerosols are rapidly transported away from the patient area by the high ventilation rates. The limit of detection of the assay was found to be 14.4 RT-qPCR Units/mL using a structurally similar surrogate virus (human coronavirus 229E); thus the possibility that virus was being aerosolized and captured at levels below this limit of detection exists and should be considered a potential limitation of this work (8) . Similarly, follow-up study with validation of the sampling parameters were not completed given restrictions in capacity; however, similar instruments and sampling parameters to those used here demonstrate positive sampling results for both infectious virus and RNA (8) . Factors contributing to the inability to isolate aerosolized virus could be lower titer of virus shed by the participants (all were healthy and younger than age 40) (11), or virus was aerosolized but remained below the assay detection limit due to the transient occupancy of the room. In fact, difficulty in recovering viral signal from these types of samples has been previously discussed (8, (12) (13) (14) (15) . It is possible that having a younger, immunocompetent population of mothers results in shedding of virus for shorter periods than the larger population as a whole (16) . Buccal and perianal swabs were negative, and participants may not have been actively shedding at delivery despite all testing positive within 5 days; the authors recognize that this is a serious limitation in interpreting the results of this brief report. However, this is less likely for Subject 5 who was positive on day of admission via nasopharyngeal swab, but who did not consent to buccal or perianal swabs. Because of the nature of the information for each subject, Ct values of subjects' positive tests obtained were not available; however, the limits of detection of the testing platforms used by the central laboratories ranged from about 50-100 genomic copies per reaction. While SARS-CoV-2 has been recovered from buccal and rectal swabs, the positive percent agreement remains 56% with buccal swabs and is more useful in early viral detection (17) . Rectal swabs have shown poorer positivity rates at 10-27% (18) (19) (20) and are likely a better test further into the disease course. Another limitation of this study is the low sample size of patients able to be enrolled during the study period. In particular, this was a consequence of the comparatively low SARS-CoV-2 positivity rate among the broader western and central Massachusetts communities during the study period, limitations related to the number of patients who both tested positive for SARS-CoV-2 and went into labor within 7 day inclusion period; and the fact that a number of patients who tested positive for SARS-CoV-2 and were symptomatic ultimately delivered by cesarean for a variety of medical and obstetric indications. The results of this study correspond to numerous other reports failing to detect a high degree of aerosolized SARS-CoV-2 in rooms with modern ventilation (21, 22) . Two of the patients were placed in negative pressure rooms, while the other four patients were placed in standard labor and delivery rooms, in a modern hospital building with open space. This work also supports other reports showing a dramatic reduction in viral transmission by those wearing masks (23) , as nearly all patients were masked at the time of vaginal delivery. Although the buccal and perianal swabs were negative, work to test the presence of virus on the inside of the patients' masks or surfaces in the room was not conducted, but would be the basis for interesting future work. The results from this work and considering the limitations mentioned above, the difficulty of identifying positive values provide an initial suggestion that transmission of SARS-CoV-2 by patients in labor is unlikely during the second stage of labor during maternal pushing efforts in modern hospital settings where masks are required. Even if some viral particles are airborne, masking and ventilation may prevent significant transmission of virus on the labor floor. The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author/s. The studies involving human participants were reviewed and approved by Institutional Review Boards at Baystate Health Medical Center (BH-20-150) and University of Massachusetts Memorial Medical Center (H00020140). The patients/participants provided their written informed consent to participate in this study. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong Nosocomial transmission of emerging viruses via aerosol-generating medical procedures Droplet fate in indoor environments, or can we prevent the spread of infection? Indoor Air Influenza virus in human exhaled breath: an observational study Turbulent gas clouds and respiratory pathogen emissions: potential implications for reducing transmission of COVID-19 Aerosol emission and superemission during human speech increase with voice loudness Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR Comparison of the performance of aerosol sampling devices for measuring infectious SARS-CoV-2 aerosols Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 Experimental aerosol survival of SARS-CoV-2 in artificial saliva and tissue culture media at medium and high humidity Duration and key determinants of infectious virus shedding in hospitalized patients Positive no-touch surfaces and undetectable SARS-CoV-2 aerosols in long-term care facilities: an attempt to understand the contributing factors and the importance of timing in air sampling campaigns SARS-CoV-2 concentrations and virus-laden aerosol size distributions in outdoor air in north and south of Italy Live SARS-CoV-2 is difficult to detect in patient aerosols. Influenza Other Respir Viruses Identification of SARS-CoV-2 RNA in healthcare heating, ventilation, and air conditioning units Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea Validation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19 SARS-CoV-2 positivity in rectal swabs: implication for possible transmission SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes SARS-CoV-2 and health care worker protection in low-risk settings: a review of modes of transmission and a novel airborne model involving inhalable particles SARS-CoV-2 and Health Care Worker Protection in Low-Risk Settings: a Review of Modes of Transmission and a Novel Airborne Model Involving Inhalable Particles Respiratory virus shedding in exhaled breath and efficacy of face masks The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.